SEP provides high quality, consolidated preclinical drug discovery and development solutions for pharmaceutical, biotechnology, and cosmetic/consumer care companies. Created to serve organizations that wish to outsource some or all of their drug discovery and development support activities, SEP’s services range from initial consultation and customized study proposals/protocols, to full study execution, result interpretation and discussion, regulatory agency compliance reporting, and guidance on the path to drug approval. Studies are expertly designed to guide and enlighten the customer, and the company’s experienced leadership and staff help advance client compounds and support informed decision-making through the regulatory process and product approval. We go beyond the talk.
Company Details
- Employees
- 12
- Founded
- 2017
- Address
- Greater Boston, Massachusetts, Us
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://www.sepscientific.com
- HQ
- Greater Boston, Massachusetts
Sep Questions
Sep's website is https://www.sepscientific.com
Sep's LinkedIn profile is https://www.linkedin.com/company/sepscientific
Sep has
12 employees.
View email and phone details for 12
employees at Sep.
Sep's industry is
Research Services
Sep's top competitors are
Quanta Preclinical,
Citeab,
Tissuevision, Inc,
Invicro,
Pourpre Growth,
Aliri Bioanalysis,
Sep,
Peak 8 Marketing,
Work-Flow,
Few Understand Marketing.
Sep's categories are Research Services
Sep's founding year is 2017
